RELATIONSHIP BETWEEN METALLOPROTEINASE AND TIMP1 EXPRESSION AND INTENSITY OF CERVICAL INFLAMMATORY REACTION IN WOMEN OF DIFFERENT AGE GROUPS WITH CERVICAL INTRAEPITHELIAL NEOPLASIA AND MICROINVASIVE CARCINOMA
https://doi.org/10.21294/1814-4861-2019-18-6-50-56
Abstract
Objective: to study the relationship between metalloproteinases and expression TIMP1 expression and intensity of inflammatory response in the cervical stroma of women with cervical intraepithelial neoplasia and microinvasive carcinoma. Material and methods. Morphological, morphometric and immunohistochemical examination of cervical biopsies in patients with cervical epithelial neoplasia (cINI–III) and microinvasive carcinoma was carried out. all patients were divided into two age groups: group 1 consisted of 95 patients of early reproductive age ranged from 18 to 35 years (mean age 28.5 ± 0.58 years) and group 2 consisted of 85 perimenopausal and menopausal patients aged 49 to 65 (mean age 55.4 ± 0.98 years). Results. In women of both age groups, the density of inflammatory cell infiltrate was shown to increase, being significantly higher in women of group 1 than in women of group 2. the increase in the expression level of metalloproteinases-2, -3, -7, and -9 with dysplasia progression was observed in women of both age groups, being also higher in group 1 women. the tIMP1 expression level was higher in group 2 women and increased with disease progression. Conclusion. In young women, pronounced and active inflammation in the cervical stroma contributes to a high potential for metalloproteinase synthesis. a higher level of tIMP1 expression in perimenopausal and menopausal women may be one of the factors contributing to a decrease in the metalloproteinase synthesis in these women.
About the Authors
M. S. Seliakova
Novosibirsk State Medical University
Russian Federation
Russian Federation
Department of Pathological Anatomy
Researcher ID (WOS): D-4555-2019
52, Krasny Prospect, 52630091-Novosibirsk, Russia
T. A. Ageeva
Novosibirsk State Medical University
Russian Federation
Russian Federation
MD, Professor, Department of Pathological Anatomy
Researcher ID (WOS): D-9135-2019
52, Krasny Prospect, 52630091-Novosibirsk, Russia
S. V. Savchenko
Novosibirsk State Medical University
Russian Federation
Russian Federation
MD, Professor, Department of Forensic Medicine
Researcher ID (WOS): А-9549-2017
52, Krasny Prospect, 52630091-Novosibirsk, Russia
References
1. Farina A.R., Mackay A.R. Gelatinase B/MMP-9 in tumor pathogenesis and progression. Cancers (Basel). 2014 Jan 27; 6(1): 240–96. doi: 10.3390/cancers6010240.
2. Vandooren J., van den Steen P.E., Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (gelatinase B/MMP-9): The next decade. Crit Rev Biochem Mol Biol. 2013 May-Jun; 48(3): 222–72. doi: 10.3109/10409238.2013.770819.
3. Wegman-Ostrosky T., Soto-Reyes E., Vidal-Millan S., SanchezCorona J. The rennin-angiotensin system meets the hallmarks of cancer. J Renin Angiotensin Aldosterone Syst. 2015 Jun; 16(2): 227–33. doi: 10.1177/1470320313496858.
4. Gershtein E.S., Kushlinskii N.E. Clinical prospects of tumor-associated proteases and their tissue inhibitors investigation in oncologic patients. Annals of the Russian academy of medical sciences. 2013; 68(5): 16–27. (in Russian).
5. Shuman Moss L.A., Jensen-Taubman S., Stetler-Stevenson W.G. Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol. 2012; 181(6): 1895–1899. doi: 10.1016/j.ajpath.2012.08.044.
6. Liu D., Guo H., Li Y., Xu X., Yang K., Bai Y. Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: A meta-analysis. PLoS One. 2012; 7(2): e31251. doi: 10.1371/journal.pone.0031251.
7. Liu H., Huang P.Y., Tang L.Q., Chen Q.Y., Zhang Y., Zhang L., Guo L., Luo D.H., Mo H.Y., Xiang Y.Q., Qiu F., Sun R., Chen M.Y., Hua Y.J., Lv X., Wang L., Zhao C., Guo X., Cao K.J., Qian C.N., Hong M.H., Mai H.Q. Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with radiotherapy. Med Oncol. 2013 Dec; 30(4): 685. doi: 10.1007/s12032-013-0685-6.
8. Rao V.H., Kansal V., Stoupa S., Agrawal D.K. MMP-1 and MMP-9 regulate epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cell. Physiol Rep. 2014 Feb 10; 2(2): e00224. doi: 10.1002/phy2.224. doi: 10.1002/phy2.224.
9. Jiang Y.N., Yan H.Q., Huang X.B., Wang Y.N., Li Q., Gao F.G. Interleukin 6 trigged ataxia-telangiectasia mutated activation facilitates lung cancer metastasis via MMP-3/MMP-13 up-regulation. Oncotarget. 2015 Dec 1; 6(38): 40719–33. doi: 10.18632/oncotarget.5825.
10. Olszewska E., Matulka M., Mroczko B., Pryczynicz A., Kemona A., Szmitkowski M., Mierzwinski J., Pietrewicz T. Diagnostic value of matrix metallopteinase-9 and tissue inhibitor of matrix metallopteinase-1 in cholesteatoma. Histol Histopathol. 2016 Mar; 31(3): 307–15. doi: 10.14670/HH-11-677.
11. Mittal R., Patel A.P., Debs L.H., Nguyen D., Patel K., Grati M., Mittal J., Yan D., Chapagain P., Liu X.Z. Intricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions. J Cell Physiol. 2016 Dec; 231(12): 2599–621. doi: 10.1002/jcp.25430.
12. Chen Q., Jin M., Yang F., Zhu J., Xiao Q., Zhang L. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflam. 2013; 2013: 928315. doi: 10.1155/2013/928315.
13. Gershtein E.S., Kushlinsky D.N., Adamyan L.V., Tereshkina I.V., Laktionov K.P. Matrix metalloproteinases and their tissue inhibitors in ovarian cancer clinical course and prognosis. Molecular medicine. 2013; 6: 11–20. (in Russian).
14. Andreeva Yu.Yu., Frank G.A. Cervical tumors (a guide for doctors). Moscow, 2012. p. 8–19. (in Russian).
15. Kurman, R.J., Carcangiu, M.L., Herrington, C.S., Young R.H. WHO Classification of Tumours of Female Reproductiw the Organs. International Agency for Research on Cancer. Lyon, 2014: 172–176.
16. Dabbs D.G. Diagnostic immunohistochemistry: theranostic and genomic applications. 3rd ed. 2010. 941: 167–169.
17. Krasnopol’skiĭ V.I., Zarochentseva N.V., Belaia Iu.M., Shipulina O.Iu., Mikheeva I.V., Serova O.F., Mel’nik T.N. Human papillomavirus infection rates among female adolescents in the Moscow Region. Russian Bulletin of Obstetrician-Gynecologist. 2010; 5: 46–49. (in Russian).
18. Korotkova E.A., Ivannikov A.A., Ognerubov N.A., Gershtein E.S., Chang V.L. Stomach cancer: molecular biological features. Tambov University Reports. Series Natural and Technical Sciences. 2014; 19(3): 957–69. (in Russian).
19. Lesnichenko I.F., Gritsaev S.V., Kapustin S.I. Matrix metalloproteinases: characterization, role in leukogenesis and prognostic value. Problems in Oncology. 2011; 57(3): 286–94. (in Russian).
20. Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. Cancer-related inflammation,the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis. 2009 Jul; 30(7): 1073–81. doi: 10.1093/carcin/bgp127.
21. Yarmolinskaya M.I., Molotkov A.S., Denisova V.M. Matrix metaloproteinases and inhibitors: clasification, mechanism of action. Journal of obstetrics and women’s diseases. 2012; 1: 113–125. (in Russian).
22. Kondakova I.V., Kakurina G.V., Spirina L.V., Cheremisina O.V., Pankova O.V., Men’shikov K.Ju. Assessment of extracellular and intracellular proteolysis in pretumor and tumor diseases of the larynx. Siberian Journal of Oncology. 2014; 3: 45–50. (in Russian).
23. Krasnopol’skiy V.I., Logutova L.S., Zarochentseva N.V., Belaya Yu.M., Tamazyan G.V., Gridchik A.L. Efficacy of vaccine prevention of HPV-associated diseases and cervical cancer in the Moscow region. Almanac of Clinical Medicine. 2015; 37: 105–110. (in Russian).
Review
For citations:
Seliakova M.S., Ageeva T.A., Savchenko S.V. RELATIONSHIP BETWEEN METALLOPROTEINASE AND TIMP1 EXPRESSION AND INTENSITY OF CERVICAL INFLAMMATORY REACTION IN WOMEN OF DIFFERENT AGE GROUPS WITH CERVICAL INTRAEPITHELIAL NEOPLASIA AND MICROINVASIVE CARCINOMA. Siberian journal of oncology. 2019;18(6):50-56. (In Russ.) https://doi.org/10.21294/1814-4861-2019-18-6-50-56
Views:
817
Email this article 
